Anti-Obesity Activity of Sanghuangporus vaninii by Inhibiting Inflammation in Mice Fed a High-Fat Diet

文献类型： 外文期刊

第一作者： Hao, Jie

作者： Hao, Jie;Jin, Xinghui;Li, Zhige;Zhu, Yanfeng;Wang, Lu;Wang, Di;Jia, Dongxu;Gao, Bo;Jiang, Xue;Wang, Di;Qi, Liangliang

作者机构： Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China;Changchun Univ Sci & Technol, Coll Life Sci & Technol, Changchun 130022, Peoples R China;Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Peoples R China;Guangxi Acad Agr Sci, Microbiol Res Inst, Nanning 530007, Peoples R China

关键词： Sanghuangpours vaninii; obesity; lipids; inflammation; TLR4/NF-kappa B

期刊名称：NUTRIENTS （ 2023影响因子：4.8； 五年影响因子：5.8 ）

ISSN：

年卷期： 2024 年 16 卷 13 期

页码：

收录情况： SCI

摘要： Obesity is an unhealthy condition associated with various diseases characterized by excess fat accumulation. However, in China, the prevalence of obesity is 14.1%, and it remains challenging to achieve weight loss or resolve this issue through clinical interventions. Sanghuangpours vaninii (SPV) is a nutritional fungus with multiple pharmacological activities and serves as an ideal dietary intervention for combating obesity. In this study, a long-term high-fat diet (HFD) was administered to induce obesity in mice. Different doses of SPV and the positive drug simvastatin (SV) were administered to mice to explore their potential anti-obesity effects. SPV regulated weight, serum lipids, and adipocyte size while inhibiting inflammation and hepatic steatosis. Compared with the vehicle-treated HFD-fed mice, the lowest decreases in total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) were 9.72%, 9.29%, and 12.29%, respectively, and the lowest increase in high-density lipoprotein cholesterol (HDL-C) was 5.88% after treatment with different doses of SPV. With SPV treatment, the analysis of gut microbiota and serum lipids revealed a significant association between lipids and inflammation-related factors, specifically sphingomyelin. Moreover, Western blotting results showed that SPV regulated the toll-like receptor (TLR4)/nuclear factor kappa B (NF-kappa B) signaling pathway in HFD-diet mice, which is related to inflammation and lipid metabolism. This research presents empirical proof of the impact of SPV therapy on obesity conditions.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序